|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/06/19 Charles River Labs Int’l, Inc. 10-Q 9/28/19 104:15M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.77M
2: EX-10.1 Material Contract HTML 59K
3: EX-10.2 Material Contract HTML 100K
4: EX-10.3 Material Contract HTML 135K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 38K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 38K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 34K
68: R1 Cover Page HTML 83K
29: R2 Condensed Consolidated Statements of Income HTML 133K
(Unaudited)
42: R3 Condensed Consolidated Statements of Comprehensive HTML 63K
Income (Unaudited)
99: R4 Condensed Consolidated Balance Sheets (Unaudited) HTML 148K
67: R5 Condensed Consolidated Balance Sheets (Unaudited) HTML 52K
(Parenthetical)
28: R6 Condensed Consolidated Statements of Cash Flows HTML 130K
(Unaudited)
41: R7 Condensed Consolidated Statements of Changes in HTML 101K
Equity (Unaudited)
102: R8 Basis of Presentation HTML 50K
64: R9 Business Acquisitions HTML 143K
23: R10 Revenue From Contracts With Customers HTML 142K
55: R11 Segment Information HTML 208K
88: R12 Supplemental Balance Sheet Information HTML 101K
76: R13 Venture Capital and Other Investments HTML 44K
24: R14 Fair Value HTML 120K
56: R15 Goodwill and Intangible Assets HTML 95K
89: R16 Long-Term Debt and Finance Lease Obligations HTML 98K
77: R17 Equity and Noncontrolling Interests HTML 131K
22: R18 Income Taxes HTML 41K
57: R19 Pension and Other Post-Retirement Benefit Plans HTML 59K
93: R20 Stock-Based Compensation HTML 57K
59: R21 Foreign Currency Contracts HTML 89K
25: R22 Restructuring and Asset Impairments HTML 151K
37: R23 Leases HTML 281K
94: R24 Commitments and Contingencies HTML 33K
60: R25 Basis of Presentation (Policies) HTML 58K
26: R26 Business Acquisitions (Tables) HTML 115K
38: R27 Revenue From Contracts With Customers (Tables) HTML 165K
95: R28 Segment Information (Tables) HTML 267K
58: R29 Supplemental Balance Sheet Information (Tables) HTML 112K
79: R30 Fair Value (Tables) HTML 106K
92: R31 Goodwill and Intangible Assets (Tables) HTML 97K
54: R32 Long-Term Debt and Finance Lease Obligations HTML 53K
(Tables)
21: R33 Equity and Noncontrolling Interests (Tables) HTML 111K
78: R34 Pension and Other Post-Retirement Benefit Plans HTML 58K
(Tables)
91: R35 Stock-Based Compensation (Tables) HTML 55K
53: R36 Foreign Currency Contracts (Tables) HTML 84K
20: R37 Restructuring and Asset Impairments (Tables) HTML 148K
80: R38 Leases (Tables) HTML 190K
90: R39 BUSINESS ACQUISITIONS - Narrative (Details) HTML 114K
62: R40 BUSINESS ACQUISITIONS - Purchase Price Allocation HTML 98K
(Details)
98: R41 BUSINESS ACQUISITIONS - Definite-Lived Intangible HTML 50K
Assets (Details)
45: R42 BUSINESS ACQUISITIONS - Pro Forma Information HTML 39K
(Details)
35: R43 REVENUE FROM CONTRACTS WITH CUSTOMERS - HTML 50K
Disaggregation of Revenues by Major Business Line
(Details)
61: R44 REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule HTML 60K
of Estimated Revenue Related to Performance
Obligations (Details)
97: R45 REVENUE FROM CONTRACTS WITH CUSTOMERS - Narrative HTML 39K
(Details)
44: R46 REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule HTML 38K
of Client Receivables, Contract Assets and
Contract Liabilities (Details)
34: R47 SEGMENT INFORMATION - Narrative (Details) HTML 31K
63: R48 SEGMENT INFORMATION - Revenue and Other Financial HTML 51K
Information by Reportable Segment (Details)
96: R49 SEGMENT INFORMATION - Reconciliation of Segment HTML 43K
Operating Income, Depreciation and Amortization,
and Capital Expenditures (Details)
81: R50 SEGMENT INFORMATION - Revenue Per Significant HTML 40K
Product or Service (Details)
70: R51 SEGMENT INFORMATION - Summary of Unallocated HTML 51K
Corporate Overhead (Details)
18: R52 SEGMENT INFORMATION - Disaggregation of Revenue by HTML 45K
Geographic Area (Details)
51: R53 Supplemental Balance Sheet Information (Details) HTML 127K
82: R54 VENTURE CAPITAL AND OTHER INVESTMENTS - Narrative HTML 52K
(Details)
71: R55 FAIR VALUE - Narrative (Details) HTML 40K
19: R56 FAIR VALUE - Fair Value of Assets and Liabilities HTML 67K
(Details)
52: R57 FAIR VALUE - Contingent Consideration (Details) HTML 42K
83: R58 GOODWILL AND INTANGIBLE ASSETS - Rollforward of HTML 45K
Goodwill (Details)
69: R59 GOODWILL AND INTANGIBLE ASSETS - Schedule of Other HTML 54K
Intangible Assets (Details)
31: R60 LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - HTML 67K
Schedule of Long-Term Debt (Details)
39: R61 LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - HTML 142K
Narrative (Details)
103: R62 EQUITY AND NONCONTROLLING INTERESTS - Earnings Per HTML 60K
Share (Details)
65: R63 EQUITY AND NONCONTROLLING INTERESTS - Narrative HTML 73K
(Details)
32: R64 EQUITY AND NONCONTROLLING INTERESTS - Treasury HTML 44K
Shares (Details)
40: R65 EQUITY AND NONCONTROLLING INTERESTS - Accumulated HTML 58K
Other Comprehensive Income (Loss) (Details)
104: R66 EQUITY AND NONCONTROLLING INTERESTS - Rollforward HTML 64K
of Redeemable Noncontrolling Interest (Details)
66: R67 Income Taxes (Details) HTML 49K
30: R68 Pension and Other Post-Retirement Benefit Plans HTML 53K
(Details)
43: R69 STOCK-BASED COMPENSATION - Stock Based HTML 43K
Compensation Expense (Details)
50: R70 STOCK-BASED COMPENSATION - Summary of Stock-Based HTML 47K
Compensation Grants (Details)
16: R71 FOREIGN CURRENCY CONTRACTS - Narrative (Details) HTML 35K
75: R72 FOREIGN CURRENCY CONTRACTS - Schedule of Notional HTML 48K
and Fair Value of Foreign Currency Contracts
(Details)
87: R73 FOREIGN CURRENCY CONTRACTS - Schedule of HTML 45K
Derivative Instruments on Statements of Income
(Details)
47: R74 RESTRUCTURING AND ASSET IMPAIRMENTS - HTML 49K
Restructuring Costs by Classification on the
Statements of Income (Details)
13: R75 RESTRUCTURING AND ASSET IMPAIRMENTS - HTML 44K
Restructuring Costs by Reportable Segment
(Details)
72: R76 RESTRUCTURING AND ASSET IMPAIRMENTS - HTML 68K
Restructuring Costs by Related to RMS
Restructuring Initiative (Details)
84: R77 RESTRUCTURING AND ASSET IMPAIRMENTS - Narrative HTML 55K
(Details)
46: R78 RESTRUCTURING AND ASSET IMPAIRMENTS - Rollforward HTML 42K
of Severance and Transition Costs Liability
(Details)
17: R79 LEASES - Schedule of Cumulative Effect of Adoption HTML 54K
of ASC 842 (Details)
49: R80 LEASES - Narrative (Details) HTML 52K
15: R81 LEASES - Right-of-Use Lease Assets and Lease HTML 47K
Liabilities in Condensed Consolidated Financial
Statements (Details)
74: R82 LEASES - Components of Operating and Finance Lease HTML 47K
Costs (Details)
86: R83 LEASES - Supplemental Cash Flow Information HTML 44K
(Details)
48: R84 LEASES - Weighted Average Remaining Lease Term and HTML 41K
Discount Rates (Details)
14: R85 LEASES - Schedule of Future Minimum Lease Payments HTML 70K
Under Non-Cancellable Leases After Adoption
(Details)
73: R86 LEASES - Schedule of Future Minimum Lease HTML 71K
Payments, Non-Cancellable Operating Leases Before
Adoption (Details)
100: R9999 Uncategorized Items - crl928201910-q.htm HTML 34K
33: XML IDEA XML File -- Filing Summary XML 191K
27: XML XBRL Instance -- crl928201910-q_htm XML 4.21M
101: EXCEL IDEA Workbook of Financial Reports XLSX 118K
9: EX-101.CAL XBRL Calculations -- crl-20190928_cal XML 364K
10: EX-101.DEF XBRL Definitions -- crl-20190928_def XML 893K
11: EX-101.LAB XBRL Labels -- crl-20190928_lab XML 2.11M
12: EX-101.PRE XBRL Presentations -- crl-20190928_pre XML 1.31M
8: EX-101.SCH XBRL Schema -- crl-20190928 XSD 199K
85: JSON XBRL Instance as JSON Data -- MetaLinks 473± 709K
36: ZIP XBRL Zipped Folder -- 0001100682-19-000030-xbrl Zip 416K
| Exhibit |
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and |
(2) | the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ James C. Foster | |||
Chairman, President and Chief Executive Officer Charles River Laboratories International, Inc. | |||
/s/ David
R. Smith | |||
Corporate Executive Vice President and Chief Financial Officer Charles River Laboratories International, Inc. | |||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/6/19 | 8-K | ||
| For Period end: | 9/28/19 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/17/21 Charles River Labs Int’l, Inc. 10-K 12/26/20 138:18M |